Insider Transactions in Q4 2019 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q4 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2019
|
David V Elkins EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,094
-23.19%
|
$390,016
$64.19 P/Share
|
|
Dec 31
2019
|
David V Elkins EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,373
+32.01%
|
-
|
|
Dec 31
2019
|
Rupert Vessey EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct |
7,910
-25.7%
|
$506,240
$64.19 P/Share
|
|
Dec 31
2019
|
Rupert Vessey EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct |
16,060
+34.29%
|
-
|
|
Dec 05
2019
|
Adam Dubow SVP,ChiefCompliance&EthicsOff. |
SELL
Open market or private sale
|
Direct |
1,740
-9.95%
|
$100,920
$58.81 P/Share
|
|
Dec 04
2019
|
Michael W Bonney Director |
BUY
Open market or private purchase
|
Direct |
88
+1.21%
|
$5,104
$58.9 P/Share
|
|
Dec 01
2019
|
Joseph Eid SVP,Head Glob. Medical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
968
-19.38%
|
$54,208
$56.94 P/Share
|
|
Dec 01
2019
|
Joseph Eid SVP,Head Glob. Medical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
2,825
+36.13%
|
-
|
|
Nov 20
2019
|
Nadim Ahmed EVP and President, Hematology |
BUY
Grant, award, or other acquisition
|
Indirect |
1,966
+50.0%
|
-
|
|
Nov 20
2019
|
Nadim Ahmed EVP and President, Hematology |
BUY
Grant, award, or other acquisition
|
Direct |
14,819
+50.0%
|
-
|
|
Nov 20
2019
|
Rupert Vessey EVP & President, Research |
BUY
Grant, award, or other acquisition
|
Indirect |
613
+50.0%
|
-
|
|
Nov 20
2019
|
Rupert Vessey EVP & President, Research |
BUY
Grant, award, or other acquisition
|
Direct |
14,178
+50.0%
|
-
|
|
Nov 20
2019
|
David V Elkins EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
195
+50.0%
|
-
|
|
Nov 20
2019
|
David V Elkins EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,908
+50.0%
|
-
|
|
Nov 05
2019
|
John E Elicker EVP, Investor Relations |
SELL
Open market or private sale
|
Direct |
15,000
-16.77%
|
$840,000
$56.66 P/Share
|
|
Nov 05
2019
|
Louis S Schmukler EVP,Pres.,Glob.Prod. & Supply |
SELL
Open market or private sale
|
Direct |
25,000
-43.89%
|
$1,400,000
$56.56 P/Share
|
|
Oct 02
2019
|
Paul Biondi SVP, Head of Strategy & BD |
SELL
Payment of exercise price or tax liability
|
Direct |
203
-3.16%
|
$9,947
$49.21 P/Share
|
|
Oct 02
2019
|
Paul Biondi SVP, Head of Strategy & BD |
BUY
Exercise of conversion of derivative security
|
Direct |
592
+8.45%
|
-
|